MedPage Today on MSN9h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney DiseaseThe dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback